Thymus aging and immune reconstitution, progresses and challenges.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic biology and preclinical studies without new clinical data or systematic methodology.
PubMed 37659170 · doi:10.1016/j.smim.2023.101837
What was done
The authors reviewed the mechanisms of age-related thymic involution, molecular regulators governing thymic function (including FOXN1, FGF, KGF, sex steroids, Notch, WNT, and microRNAs), sex differences, and therapeutic strategies for thymic and immune reconstitution.
What was found
The abstract reports no quantitative metrics or effect sizes. It describes the key features of thymic involution as epithelial structure disruption, adipogenesis, and thymocyte developmental arrest. It notes that sustained thymic regeneration has not been achieved through sex steroid ablation alone, whereas preclinical models suggest long-term reconstitution is achievable via adoptive transfer of in vitro-derived progenitor T (proT) cells, particularly when combined with cytokine support and sex-steroid inhibition.
Why it matters
Understanding the multi-pathway drivers of thymic involution informs strategies to reverse age-related immune decline and rebuild T-cell production after immunodepletion.
Limits
The abstract describes a narrative review rather than a systematic synthesis. Evidence for therapeutic interventions remains limited to preclinical models, and no human clinical efficacy or safety data are reported.
Cited by
- supports Thymic involution starting at puberty is primarily driven by androgens, estrogens, progestins, and corticosteroids.